Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body - the first programs will focus on liver disease
- May 1
- 1 min read
CEO Ritish Patnaik explains the challenges of understanding DNA in the blood for people who have chronic disease, and the idea behind the company's 'Whole Body Atlas' to make sense of it. Curve will start by creating products that track when cirrhosis transitions to its end stages and cancer, and MASH Monitoring.









.png)
